health pharma news today obesity drugs glp-1 today Chart: 1 in 8 Americans Now Use for Weight Loss The GLP-1 Revolution: How Next-Generation

But those trials havent yet been completed for opioid use disorder specifically

PMC 3776106

503A Compounding Pharmacies Limitations on Compounding Copies of Commercial Drugs The SAFE Drugs Act proposes to amend Section 503A of the FDCA to (i) codify the definition of essentially a copy of a commercially available drug product and (ii) prevent compounding pharmacies from compounding more than 20 units per month of any drug that is essentially a copy of a commercially available product unless tailored to an individual patient

k - o , cFOS + whole-brain imaging data came from mice in Fig

doi: 10.1056/NEJMoa1411892 124 ButlerAEJansonJBonner-WeirSRitzelRRizzaRAButlerPC

I believe the above shows the data for whatever subset of people were still cooperating on each week